ENTERA BIO LTD. Shares Outstanding (Cover Page)
ENTERA BIO LTD. (ENTX) had Shares Outstanding (Cover Page) of 173.14 million shares as of 2026-08-03, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-07
- 2026-08-03: Entity Common Stock, Shares Outstanding 173.14M shares.
- 2026-05-04: Entity Common Stock, Shares Outstanding 49.23M shares.
- 2026-03-23: Entity Common Stock, Shares Outstanding 46.62M shares.
- 2025-11-10: Entity Common Stock, Shares Outstanding 45.86M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-03 | 173.14M shares 10-Q · filed 2026-08-07 |
| 2026-05-04 | 49.23M shares 10-Q · filed 2026-05-08 |
| 2026-03-23 | 46.62M shares 10-K · filed 2026-03-27 |
| 2025-11-10 | 45.86M shares 10-Q · filed 2025-11-14 |
| 2025-08-04 | 45.66M shares 10-Q · filed 2025-08-08 |
| 2025-05-05 | 45.45M shares 10-Q · filed 2025-05-09 |
| 2025-03-20 | 45.42M shares 10-K · filed 2025-03-28 |
| 2024-11-04 | 36.83M shares 10-Q · filed 2024-11-08 |
| 2024-08-05 | 36.32M shares 10-Q · filed 2024-08-09 |
| 2024-05-06 | 35.79M shares 10-Q · filed 2024-05-10 |
| 2024-03-01 | 35.48M shares 10-K · filed 2024-03-08 |
| 2023-11-01 | 28.81M shares 10-Q · filed 2023-11-14 |
| 2023-08-07 | 28.81M shares 10-Q · filed 2023-08-11 |
| 2023-05-01 | 28.81M shares 10-Q · filed 2023-05-05 |
| 2023-03-27 | 28.81M shares 10-K · filed 2023-03-31 |
| 2022-11-07 | 28.81M shares 10-Q · filed 2022-11-10 |
| 2022-06-30 | 28.81M shares 10-Q · filed 2022-08-11 |
| 2022-04-28 | 28.80M shares 10-K/A · filed 2022-04-29 |
| 2022-03-31 | 28.80M shares 10-Q · filed 2022-05-12 |
| 2022-03-01 | 28.80M shares 10-K · filed 2022-03-08 |
| 2020-12-31 | 23.74M shares 20-F · filed 2021-03-18 |
| 2019-12-31 | 18.20M shares 20-F · filed 2020-03-26 |
| 2018-12-31 | 11.46M shares 20-F · filed 2019-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |